AI can evaluate connections from data that may appear irrelevant to a person, which could help pharmaceutical companies avoid distributing contaminated products, Marla Phillips, director of Cincinnati-based Xavier Health, told WVXU.
Ms. Phillips cited a 2008 incident in which 81 people died after being injected with contaminated heparin, an anticoagulant. Using computer systems to evaluate data sources could have predicted a problem with the drug before it was used, she added.
More articles on supply chain:
US Bioservices to pay $13.4M to resolve kickback suit
Samsung widens stake in prescription drug market through partnership with Japanese pharmaceutical company
Patients brace for price of ‘breakthrough’ leukemia drug CTL019
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.